Inhibition of pancreatic adenocarcinoma cell growth by lovastatin
- 1 September 1992
- journal article
- Published by Elsevier in Gastroenterology
- Vol. 103 (3) , 982-989
- https://doi.org/10.1016/0016-5085(92)90032-t
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Frequent Glycine‐to‐Aspartic Acid Mutations at Codon 12 of c‐Ki‐ras Gene in Human Pancreatic Cancer in JapaneseJapanese Journal of Cancer Research, 1990
- Pancreatic ductal adenocarcinomas induced in syrian hamsters by N‐nitrosobis (2‐oxopropyl) amine contain a c‐Ki‐ras oncogene with a point‐mutated codon 12Molecular Carcinogenesis, 1990
- Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genesPublished by Elsevier ,1988
- Incidence of ras gene mutations in neuroblastomaEuropean Journal of Pediatrics, 1988
- ras GENESAnnual Review of Biochemistry, 1987
- Pancreatic neoplasia induced by ras expression in acinar cells of transgenic miceCell, 1987
- Effects of mevinolin and mevalonate on cell growth in several transformed cell linesJournal of Cellular Physiology, 1986
- Suppression of murine neuroblastoma growth in vivo by mevinolin, a competitive inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A reductase.Journal of Clinical Investigation, 1985
- Inhibitory Effects on Lipid Metabolismn in Cultured Cells of ML‐236B, a Potent Inhibitor of 3‐Hydroxt‐3‐methylglutaryl‐Cornzyme‐A ReductaseEuropean Journal of Biochemistry, 1978
- Competitive inhibition of 3‐hydroxy‐3‐methylglutaryl coenzyme a reductase by ML‐236A and ML‐236B fungal metabolites, having hypocholesterolemic activityFEBS Letters, 1976